| Literature DB >> 34856629 |
Eakapong Tamboon1, Phetmany Sihavong2,3, Nakarin Kitkumthorn1, Dusit Bumalee3, Tawepong Arayapisit4, Puangwan Lapthanasupkul3.
Abstract
OBJECTIVE: Oral verrucous squamous cell carcinoma or oral verrucous carcinoma (OVC) is a rare verrucous variant of oral squamous cell carcinoma (OSCC), which accounts for 2 to 12% of all oral carcinomas. Oral verrucous hyperplasia (OVH) is clinically similar to OVC and has been proposed to be a precursor lesion of OVC. Etiopathogenesis of both lesions is still inconspicuous. Oncogenic viruses such as human papillomavirus (HPV) and Epstein-Barr virus (EBV) have been reported to be associated with some cases of OSCC, and we hypothesized that it may act as a causative agent of these verrucous lesions. This study aimed to investigate frequency of HPV and EBV infections in OVC and OVH.Entities:
Year: 2021 PMID: 34856629 PMCID: PMC9339939 DOI: 10.1055/s-0041-1735907
Source DB: PubMed Journal: Eur J Dent
Fig. 1Histopathologic features of oral verrucous squamous cell carcinoma (OVSCC) and oral verrucous hyperplasia (OVH). ( A, C, E ) oral verrucous carcinoma (OVC) showing papillary epithelial hyperplasia with bulbous rete ridges pushing into the connective tissue. ( B, D, F ) OVH showing epithelial proliferation with verrucous surface elevating from the adjacent normal epithelium.
Properties of oligonucleotide primer sequences and conditions for PCR analyses in this study
| Detection | Primer | Amplicon size (bp) | Sequence 5′-3′ |
|---|---|---|---|
| Internal control | GAPDH forward | 150 | CAGCCGCATCTTCTTTTG |
| GAPDH reverse | CAACAATATCCACTTTAC | ||
| EBV DNA | LMP1 forward | 129 | CCAGACAGCCAACAATTG |
| LMP1 reverse | GGTAGAAGACCCCCTAC | ||
| HPV DNA | GP5+ | 150 | TTTGTTACTGTGGTAGATACTAC |
| GP6+ | CTTATACTAAATGTCAAATAAAAAG |
Clinical information of OVC and OVH cases
| Characteristics |
OVC (
|
OVH (
|
|---|---|---|
| Age, mean (range) years | 75.44 (51–103) | 70.5 (59–84) |
| Sex | ||
| Female | 21 (77.8%) | 6 (75%) |
| Male | 6 (22.2%) | 2 (25%) |
| Location | ||
| Gingiva/alveolar mucosa | 5 (18.5%) | 4 (50%) |
| Buccal mucosa | 8 (29.6%) | 4 (50%) |
| Lip | 3 (11.1%) | 0 |
| Tongue | 5 (18.5%) | 0 |
| Palate | 3 (11.1%) | 0 |
| Multiple sites |
3
| 0 |
Abbreviations: OVC, oral verrucous carcinoma; OVH, oral verrucous hyperplasia.
Two cases were located at the lip and buccal mucosa and the other case was found at the gingiva and buccal mucosa.
Fig. 2The 1% (w/v) agarose gel electrophoresis of polymerase chain reaction (PCR) products. Lane M: 100 bp ladder; Lane N: negative control; Lane 1 = positive control for human papillomavirus (HPV) (HeLa cell); Lane 2 =positive control for Epstein–Barr virus (EBV) (B95-8 cell); Lane 3-5 = oral verrucous carcinoma (OVC) samples; Lane 6-8 = oral verrucous hyperplasia (OVH) samples. ( A ): Representative gel pictures showing polymerase chain reaction (PCR) products positive for GAPDH (150 bp) in all samples of OVC and OVH. ( B ): Representative gel pictures showing PCR products negative for HPV, only positive control showed amplification (150 bp). ( C ): Representative gel pictures showing PCR products negative for EBV, only positive control showed amplification (129bp).
Overview of previous studies investigating HPV in OVC and OVH
| Reference | Number and type of samples | Method of HPV detection (primer) | Detected HPV types (overall HPV prevalence in %) |
|---|---|---|---|
|
Shroyer and Greer
| - 14 OVH | - ISH (31/33/35) | - 16 (28.5%) by PCR in OVH |
|
Noble-Topham et al
| - 25 OVC | - PCR (6b/11,16,18 primers) | - 6/11, 11, 16, 18, 16/18 (48%) |
|
Shroyer and Greer
| - 17 OVC | - PCR and DNA slot-blot hybridization | - 7/17 (41%) |
|
Mitsuishi et al
| -5 OVC | - PCR, sequence analysis and restriction fragment length polymorphism | - 20 (74.8%) |
|
Fujita et al
| - 23 OVC (FFPE) | - PCR (SPF primer) | - 18, 6, 74, 11, 33 (48%) by PCR |
|
Saghravanian et al
| - 21 OVC (FFPE) | - PCR (GP5/GP6) | - 16/18 (14.3%) |
|
de Spindula-Filho
| - 8 OVC | - PCR (GP5/GP6) | - No HPV infection in OVC |
|
Lin et al
| - 48 OVC | - IHC (16/18 E6 protein) | - Very low labeling indices of HPV 16/18 E6 protein in both OVC (0.5%) and OVH (0.3%) |
|
del Pino et al
| - 5 OVC | - PCR (GP5/GP6) | - Only 1 case (20%) in OVC |
|
Stokes et al
| - 7 OVC | - PCR (GP5/GP6) | - Only 1 case (14.28%) by PCR |
|
Sritippho et al
| - 4 OVC | - Real-time PCR (specific primer for HPV-type 16 and 18) | - Only 1 case (25%) |
Abbreviations: FFPE, formalin-fixed paraffin-embedded; HPV, human papillomavirus virus; ISH, in situ hybridization; OVC, oral verrucous carcinoma; OVH, oral verrucous hyperplasia; PCR, polymerase chain reaction.